Lucia Vernerova
Prague, PR 12850, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Alterations in systemic and skeletal muscle myostatin regulation are most prominent at disease onset and associate with muscle-related outcomes in idiopathic inflammatory myopathies.
Journal: Arthritis research & therapy
Published: March 08, 2026
Cellular miRNA-31 and miRNA-125b as predictors of remission and major disease improvement in patients with early rheumatoid arthritis.
Journal: Scientific reports
Published: June 12, 2025
Vitamin D and its receptor in skeletal muscle are associated with muscle disease manifestation, lipid metabolism and physical fitness of patients with myositis.
Journal: Arthritis research & therapy
Published: November 22, 2024
Muscle-specific miRNAs in plasma and skeletal muscle of patients with idiopathic inflammatory myopathy are modulated by disease and training.
Journal: Rheumatology (Oxford, England)
Published: July 12, 2024
MyomiRs in cultured muscle cells from patients with idiopathic inflammatory myopathy are modulated by disease but not by 6-month exercise training.
Journal: Clinical and experimental rheumatology
Published: September 20, 2021
The effect of a 24-week training focused on activities of daily living, muscle strengthening, and stability in idiopathic inflammatory myopathies: a monocentric controlled study with follow-up.
Journal: Arthritis research & therapy
Published: January 26, 2021
Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment response.
Journal: Scientific reports
Published: November 25, 2020
Altered dynamics of lipid metabolism in muscle cells from patients with idiopathic inflammatory myopathy is ameliorated by 6 months of training.
Journal: The Journal of physiology
Published: July 08, 2020
Clusterin is upregulated in serum and muscle tissue in idiopathic inflammatory myopathies and associates with clinical disease activity and cytokine profile.
Journal: Clinical and experimental rheumatology
Published: March 09, 2020
Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies.
Journal: Rheumatology (Oxford, England)
Published: July 11, 2019
Contribution of Genetic Factors to Lower DHEAS in Patients with Rheumatoid Arthritis.
Journal: Cellular and molecular neurobiology
Published: March 31, 2017
MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: April 07, 2016
Last Updated: 09/26/2026